• For investors
  • For customers
  • Get in touch
  • Join our investigator network
  • About us
    • Our vision
    • Core values
    • Management team
      • Candace Kendle, PharmD
      • Christopher C. Bergen, MBA
      • Simon S. Higginbotham
      • Stephen A. Cutler, PhD, MBA
      • Keith A. Cheesman
      • Jarrod B. Pontius
    • Company milestones
    • Awards and recognition
  • Clinical development
    • Early stage
      • Our expertise
        • High-risk molecules
        • Pharmacodynamics
        • Abuse liability
        • Alcohol interaction
        • CNS disorders
        • Bioequivalence
        • Patient populations
        • QTc studies
        • Scientific toybox
      • Our locations
    • Late stage
      • Our expertise
        • Phase II-III
        • Phase IIIB-IV
        • Health economics / Outcomes research
        • Observational studies
        • Registries and epidemiology
      • Our locations
    • Clinical trial elements
      • Getting started
        • Site start-up management
        • Feasibility
        • Site ID
        • Clinical trials regulatory
        • Patient recruitment
        • Start-up technology
        • Investigator education
      • Right advice
        • Strategic planning
        • Non clinical consulting
        • CMC
        • Consulting/Submissions
        • Biologicals
        • Established drug substances
        • Devices
        • Agency meetings
        • Pediatric Development plans
        • Life cycle management
        • Chemical entities
      • Tech tools
      • Managing sites
        • Remote monitoring
        • On-site monitoring
        • Data management
        • Clinical data technology
      • Medical know-how
        • Cardiology
        • CNS and Neurology
        • Endocrinology
        • Infectious diseases
        • Oncology
        • Inflammatory diseases
        • Other
          • Respiratory
          • Ophthalmology
          • Gastrointestinal
      • Protecting patients
        • Clinical safety
        • Post-marketing safety
        • Risk management
        • Endpoint adjudication - TrialEAS™
      • Medical writing
        • Protocols
        • Clinical study reports
        • Publications
        • Regulatory submissions
        • Patient narratives
      • Delivering data
        • Biostatistics
        • Statistical programming
        • CDISC
        • Adaptive design
        • Submission support
  • Partnerships / RFI
    • Partnership approaches
    • Global full service
    • FSP
    • Resourcing
    • Asset transfers
    • Proposal for you
  • Taking part in a clinical study
    • What is a clinical study?
    • Our center in Utrecht, The Netherlands
    • Our center in Toronto, Canada
    • Our center in Morgantown, W.Va., USA
  • Career with us
    • Work with us
    • Why Kendle?
    • Global locations
    • Entry level
      • Training
      • Links
    • Experienced
    • Apply here
  • Resource warehouse
    • Media room
    • Therapeutic expertise
    • Webcasts and Videos
    • Presentations
    • Brochures and factsheets
    • Events
    • News
    • Investor materials
  • Geographies
    • North America
    • Europe
    • Asia/Pacific
    • Latin America
    • Africa
    • Emerging markets
    • Interactive map